CLINICAL_TRIALS
research
· 2026-01-20
Clinical Trial Update: IL13Rα2 CAR-T for Patients With r/r Glioma [Phase 1]
Summary
Phase 1 trial of IL13Rα2-targeted CAR-T therapy for recurrent or relapsed glioma; the study status is suspended.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yang Zhang | Conditions: Glioma | Phase 1 | Status: SUSPENDED